Cargando…
P09.12 SARS- CoV2 Impact in a Spanish Lung Cancer Cohort?
Autores principales: | Nunez-Garcia, B., Nuñez-Garcia, B., Morito, A., Martínez, M., Traseira, C., Aguado, R., Garitaonaindía, Y., Visedo, G., Franco, F., Calvo, V., Provencio, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976860/ http://dx.doi.org/10.1016/j.jtho.2021.01.440 |
Ejemplares similares
-
1733P Real-world data: Cancer and SARS-CoV-2 infection
por: Nunez Garcia, B., et al.
Publicado: (2020) -
Cancer and SARS-CoV-2 Infection: A Third-Level Hospital Experience
por: Calvo, Virginia, et al.
Publicado: (2021) -
EP06.01-017 Clinical Impact of SARS-CoV2 Pandemic in the Diagnosis of Early-Stage Thoracic Tumours
por: Garitaonaindía Díaz, Y., et al.
Publicado: (2022) -
P31.03 The Impact of the COVID-19 Pandemic on a Thoracic Tumor Unit of a Tertiary Hospital in Spain
por: Cudero, L., et al.
Publicado: (2021) -
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium
por: Balis, Frank M., et al.
Publicado: (2016)